retatrutide clinical trial weight loss data How long does take to work Preventing obesity-related cancer with the

Many patients may find 8mg offers the best balance of efficacy and tolerability

The available evidence on retatrutide's GI effects including its potential to alter bowel habits comes primarily from a Phase 2 clinical trial (Jastreboff et al., NEJM 2023)

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimers disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials

Begin tracking protein intake

Not for resale or use outside of controlled research settings

For a true head-to-head comparison of semaglutide versus tirzepatide, the SURMOUNT-5 trial (Aronne et al., NEJM 2024, NEJMoa2416394) provides a clear advantage for tirzepatide